Biotech News

National Research Corporation Declares Quarterly Dividend

National Research Corporation (NRC)National Research CorporationCompany update

National Research Corporation, dba NRC Health, (NASDAQ:NRC) announced that its Board of Directors has declared a quarterly cash dividend of $0.12 (twelve cents) per share payable Friday, January 12, 2024, to shareholders of record as of the close of business on Friday, December 29, 2023.

For more than 40 years, NRC Health (NASDAQ: NRC) has led the charge to humanize healthcare and support organizations in their understanding of each unique individual. NRC Health’s commitment to Human Understanding® helps leading healthcare systems get to know each person they serve not as point-in-time insights, but as an ongoing relationship. Guided by its uniquely empathic heritage, NRC Health’s patient-focused approach, unmatched market research, and emphasis on consumer preferences are transforming the healthcare experience, creating strong outcomes for patients and entire healthcare systems. NRC Health is ranked #1 for Patient Experience Improvement in the 2023 Best in KLAS report.

Related news

National Research Corporation

Healthcare Experience Improvement Company NRC Health provides healthcare organizations with consumer, patient, employee, and market insights intended to improve experience, loyalty, reputation, and organizational performance. Continuous Feedback and Insight The company collects and analyzes feedback across the care journey rather than...

Recent company news

Stock data

Close
20.35 USD
Market cap
441.49M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States